[带有多炎的eosinophilic granulomatosis中的周围神经病变]
1Department of Neurotherapeutics, Yamaguchi University of Medicine.
Brain and nerve = Shinkei kenkyu no shinpo
|May 14, 2024
概括
带有多炎 (EGPA) 的埃索诺菲尔颗粒炎是一种小血管血管炎. EGPA通常会引起神经病变,影响90%的异红蛋白患者,需要紧急治疗.
科学领域:
- 免疫学 免疫学 免疫学
- 神经学 神经学
- 类风湿病学 类风湿病学
背景情况:
- 带有多炎的埃索诺菲尔颗粒炎 (EGPA) 是一种与抗中性细胞体自身抗体相关的抗中性细胞体血管炎.
- 它涉及小血管炎症.
- EGPA可以导致显著的外周神经系统并发症.
研究的目的:
- 要总结EGPA诱导的神经病变的关键方面.
- 为了强调这种神经复杂症的患病率和潜在严重程度.
主要方法:
- 对EGPA和相关神经病变的现有文献的综述.
- 对临床数据关于患者结果的分析.
主要成果:
- 周围血液中埃索诺菲利亚是EGPA的一个常见特征.
- 大约90%的EGPA患者患有神经病变.
- 这些神经病变并发症可能很严重,需要立即进行医疗干预.
结论:
- EGPA经常导致神经病变,这是一个严重的并发症.
- 早期识别和治疗对于管理EGPA诱导的神经病变至关重要.
相关概念视频
Peripheral Nervous System: Ganglia and Nerves
The Peripheral Nervous System (PNS) is a crucial component of the body's neural network, extending beyond the central nervous system (CNS) to bridge the gap between the CNS and the external environment. It encompasses nerves, ganglia, and sensory receptors.
Nerves
The nerve is a bundle of axons that serves as the communication highway in the PNS. Each nerve is ensheathed in a protective layer of connective tissue called the epineurium. This outermost layer safeguards the nerve and supports the...
Nerves
The nerve is a bundle of axons that serves as the communication highway in the PNS. Each nerve is ensheathed in a protective layer of connective tissue called the epineurium. This outermost layer safeguards the nerve and supports the...
Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Esophageal Achalasia
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...


